UBS Group
TIL icon

UBS Group’s Instil Bio TIL Stock Holding History

UBS Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
177,423
+171,045
+2,682% +$1.38M ﹤0.01% 5455
2026
Q1 		$52.6K Buy
6,378
+6,019
+1,677% +$48.8K ﹤0.01% 7341
2025
Q4 		$3.95K Sell
359
-5,262
-94% -$77.8K ﹤0.01% 8914
2025
Q3 		$100K Sell
5,621
-10,598
-65% -$269K ﹤0.01% 7128
2025
Q2 		$338K Sell
16,219
-1,061
-6% -$22.2K ﹤0.01% 6347
2025
Q1 		$300K Sell
17,280
-73,806
-81% -$1.53M ﹤0.01% 6241
2024
Q4 		$1.74M Buy
91,086
+90,955
+69,431% +$2.77M ﹤0.01% 4855
2024
Q3 		$8.82K Buy
131
+99
+309% +$2.33K ﹤0.01% 7819
2024
Q2 		$329 Sell
32
-227
-88% -$2.45K ﹤0.01% 8977
2024
Q1 		$2.8K Buy
259
+138
+114% +$1.51K ﹤0.01% 7826
2023
Q4 		$922 Buy
121
+100
+476% +$723 ﹤0.01% 8475
2023
Q3 		$182 Buy
21
+1
+5% +$10 ﹤0.01% 8737
2023
Q2 		$224 Sell
20
-1,246
-98% -$15.2K ﹤0.01% 8368
2023
Q1 		$16.7K Buy
1,266
+293
+30% +$4.33K ﹤0.01% 7216
2022
Q4 		$12.3K Buy
973
+957
+5,981% +$47.3K ﹤0.01% 8296
2022
Q3 		$1K Buy
+16
New +$1.83K ﹤0.01% 10040
2022
Q2 		– Sell
-1
Closed – – 10940
2022
Q1 		$0 Sell
1
-527
-100% -$123K ﹤0.01% 10894
2021
Q4 		$181K Buy
+528
New +$204K ﹤0.01% 5787
2021
Q3 		– Sell
-36
Closed -$14K – 10081
2021
Q2 		$14K Buy
+36
New +$13.4K ﹤0.01% 7718

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

UBS Group's TIL Position: Q2 2026 in Review

UBS Group increased its Instil Bio (TIL) stake by 2,682% in Q2 2026, buying an estimated $1.38M and bringing the position to 177,423 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #5455.

UBS Group first reported a position in TIL in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.74M in Q4 2024. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • UBS Group held 177,423 shares of Instil Bio worth $1.36M as of Q2 2026.
  • UBS Group bought 171,045 Instil Bio shares in Q2 2026, an estimated $1.38M.
  • Instil Bio made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5455 holding.
  • UBS Group first reported a position in Instil Bio in Q2 2021 and has held it in 19 quarters since.
  • UBS Group's Instil Bio position peaked at $1.74M in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.